Literature DB >> 2896812

Cannabis and schizophrenia.

S Andréasson, P Allebeck, A Engström, U Rydberg.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 2896812     DOI： 10.1016/s0140-6736(88)91823-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.

Authors:  A M Auther; D McLaughlin; R E Carrión; P Nagachandran; C U Correll; B A Cornblatt
Journal:  Psychol Med       Date:  2012-04-30       Impact factor: 7.723

Review 2.  Substance use in clinical high risk for psychosis: a review of the literature.

Authors:  Jean Addington; Nevicia Case; Majid M Saleem; Andrea M Auther; Barbara A Cornblatt; Kristin S Cadenhead
Journal:  Early Interv Psychiatry       Date:  2013-11-14       Impact factor: 2.732

3.  Psychosis risk as a function of age at onset: a comparison between early- and late-onset psychosis in a general population sample.

Authors:  Sebastian Köhler; Jim van Os; Ron de Graaf; Wilma Vollebergh; Frans Verhey; Lydia Krabbendam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-03-12       Impact factor: 4.328

4.  Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.

Authors:  Mathieu Lafourcade; Izaskun Elezgarai; Susana Mato; Yamina Bakiri; Pedro Grandes; Olivier J Manzoni
Journal:  PLoS One       Date:  2007-08-08       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.